ConductScience.org, home

Gene · 2176

Papers2,586

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

741 to 760 of 2,586

Download this page as JSON
TitleJournalYearPMIDFound bySource
Mixed Methods in Tactical Analysis Through Polar Coordinates and Function Estimation: The Transition Play in ACB Basketball.Front Sports Act Living202134632379PubTator, text miningPubMed
Microarray analysis of differentially expressed long non-coding RNAs in daidzein-treated lung cancer cells.Oncol Lett202134630702PubTator, text miningPubMed
Combination ATR and PARP Inhibitor (CAPRI): A phase 2 study of ceralasertib plus olaparib in patients with recurrent, platinum-resistant epithelial ovarian cancer.Gynecol Oncol202134620496PubTator, text miningPubMed
Letermovir Prophylaxis for Cytomegalovirus Infection in Allogeneic Stem Cell Transplantation: A Real-World Experience.Front Oncol202134616684PubTator, text miningPubMed
Identifying Chinese Medicine Patterns of Tension-Type Headache and Understanding Its Subgroups.Evid Based Complement Alternat Med202134603470PubTator, text miningPubMed
Design and user experience testing of a polygenic score report: a qualitative study of prospective users.BMC Med Genomics202134598685PubTator, text miningPubMed
A protein interaction landscape of breast cancer.Science202134591612PubTator, text miningPubMed
Differentially expressed genes in Alzheimer's disease highlighting the roles of microglia genes including OLR1 and astrocyte gene CDK2AP1.Brain Behav Immun Health202134589742PubTator, text miningPubMed
B4GALNT2 Gene Promotes Proliferation, and Invasiveness and Migration Abilities of Model Triple Negative Breast Cancer (TNBC) Cells by Interacting With HLA-B Protein.Front Oncol202134589428PubTator, text miningPubMed
A comprehensive molecular study identified 12 complementation groups with 56 novel FANC gene variants in Indian Fanconi anemia subjects.Hum Mutat202134585473PubTator, text miningPubMed
Randomized Phase II Study of PARP Inhibitor ABT-888 (Veliparib) with Modified FOLFIRI versus FOLFIRI as Second-line Treatment of Metastatic Pancreatic Cancer: SWOG S1513.Clin Cancer Res202134580114PubTator, text miningPubMed
Serum Albumin: A Multifaced Enzyme.Int J Mol Sci202134576249PubTator, text miningPubMed
Determinants of Homologous Recombination Deficiency in Pancreatic Cancer.Cancers (Basel)202134572943PubTator, text miningPubMed
Site-directed RNA editing: recent advances and open challenges.RNA Biol202134569891PubTator, text miningPubMed
Plant Variety Selection Using Interaction Classes Derived From Factor Analytic Linear Mixed Models: Models With Independent Variety Effects.Front Plant Sci202134567051PubTator, text miningPubMed
Restriction factor compendium for influenza A virus reveals a mechanism for evasion of autophagy.Nat Microbiol202134556855PubTator, text miningPubMed
A comprehensive map of alternative polyadenylation in African American and European American lung cancer patients.Nat Commun202134556645PubTator, text miningPubMed
A Replication stress biomarker is associated with response to gemcitabine versus combined gemcitabine and ATR inhibitor therapy in ovarian cancer.Nat Commun202134552099PubTator, text miningPubMed
An Immune-Associated Genomic Signature Effectively Predicts Pathologic Complete Response to Neoadjuvant Paclitaxel and Anthracycline-Based Chemotherapy in Breast Cancer.Front Immunol202134526986PubTator, text miningPubMed
Phenol-soluble modulins α are major virulence factors of Staphylococcus aureus secretome promoting inflammatory response in human epidermis.Virulence202134516337PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/2176/papers?page=38